July 23, 2008

USB Webcam

pc-microscope.jpg

What could possibly be a better gift for your family than this? This USB Microscope, Webcam, Hub combo gadget is a must have! Want to take a closer look at the soda cap that has been sitting under your desk for the last three years? Here’s a way to do so.

The Microscope part of this gadget actually works without the USB, though when plugged into the USB port, you can view the specimen on your computer screen, and even add text and special effects to whatever scientific monstrosity you can view with this device. You’ll need Windows XP and 2 AA batteries to operate this toy. Just don’t go feeding it to your dog. It’s not a USB Dog Toy. And we doubt your dog is interested anyway. Get your own for $70. — Andrew Dobrow

July 22, 2008

Bioinformatics Pioneer Will Lead New Initiatives at Emory University

WEBWIRE – Monday, July 21, 2008

Joel H. Saltz, MD, PhD, a pioneer in the fields of high-performance computing and biomedical informatics, will join Emory University’s Woodruff Health Sciences Center in September as director of the Center for Comprehensive Informatics and as Emory Healthcare’s Chief Medical Information Officer. The announcement was made by Fred Sanfilippo, MD, PhD, Emory executive vice president for health affairs, CEO of the Woodruff Health Sciences Center and chairman of Emory Healthcare.

Saltz will help develop and lead new initiatives that are expected to fuel scientific discovery in health and medicine and to empower more precise and scientifically informed decision-making in patient care, says Sanfilippo.

Saltz currently serves as professor and chair of the Department of Biomedical Informatics and professor in the Department of Computer Science and Engineering at The Ohio State University (OSU), Davis Endowed Chair of Cancer at OSU, and a senior fellow of the Ohio Supercomputer Center. Prior to coming to OSU, Saltz was professor of pathology and informatics in the Department of Pathology at Johns Hopkins School of Medicine and professor in the Department of Computer Science at the University of Maryland.

With more than $4.7 million in National Institutes of Health funding and some $70 million in total active grant funding, Saltz has more than 325 publications and 70 invited presentations to his credit. He is trained both as a computer scientist and as a medical scientist. He received his MD and his PhD (computer science) degrees at Duke University. He completed a residency in clinical pathology at Johns Hopkins University and is a board-certified clinical pathologist.

As chief medical information officer for Emory Healthcare, Saltz will direct strategic planning and implementation of the comprehensive Emory Medical Information Enterprise. He will guide recruitment, research and resource allocation for informatics programs across academic departments. Additionally, he will lead the further development of Emory’s external partnerships in bioinformatics, including those with the Georgia Institute of Technology, Children’s Healthcare of Atlanta, Morehouse School of Medicine, the Atlanta Veterans Affairs Medical Center, the Georgia Research Alliance and the Georgia Cancer Coalition.

"Dr. Saltz will help us achieve our vision of transforming health and healing by applying computer science to the overarching challenges facing the biological and biomedical sciences" says Sanfilippo. "He will accelerate our already outstanding momentum in biomedical research as we continue to increase the quality of care we provide to our patients and their families. His addition to our faculty is a significant step forward toward our goal of being the 21st century model of an academic health sciences and health services center"

Among his many noteworthy achievements, Saltz has been a leader in the cancer Biomedical Informatics Grid (caBIG), an initiative of the National Cancer Institute Center for Biomedical Informatics and Information Technology. The initiative helps cancer researchers, clinicians and patients share relevant data and information, speed translation of new cancer diagnostics and therapies from the laboratory to the community and help fully realize the potential of predictive health. Saltz has spearheaded other groundbreaking biomedical information projects in cardiovascular medicine, clinical research and imaging. While at Johns Hopkins in 1996, he created prototypes for the first virtual microscope software.

The field of bioinformatics uses computer technology to analyze and interpret a wealth of biological data generated from fundamental research and translates that information into the knowledge necessary to develop medical innovations. Biomedical informatics will enhance established and emerging Emory programs in the neurosciences, predictive health, computational and life sciences, transplantation, global health, vaccines and inflammation, regenerative medicine, respiratory health, cardiovascular health, cancer and clinical trials.

July 21, 2008

Some pathology experts say staffing, funding constraints may be behind surge in testing errors

Medscape (7/19, Gandey) reported that a number of "[e]xperts say staffing and funding constraints are making it difficult for pathologists to do their jobs, and it is more likely that testing errors will occur." Meanwhile, pathologists in Canada came "under fire recently after a series of mistakes in the lab were made public." In Newfoundland, "nearly 400 breast cancer cases went undetected over an eight-year period," and approximately "100 of these women died after their test results were misread." Yet, the problem "should encourage oncologists to remain vigilant and verify results." Jared Schwartz, M.D., "president of the College of American Pathologists," suggested "that doctors adopt a more collaborative approach, and work more closely with one another." Noting that "pathology, like most areas of medicine, is an art as well as a science," Dr. Schwartz said, "At the end of the day, it is an opinion." But, "[o]ur goal is always to provide the most scientifically accurate diagnosis that we can," and even though "results can vary,...we have to work with that," he concluded.

The Startling Truth About Doctors

Medical errors seem to a part of medical practice.  It makes everyone, patients and physicians take notice.  While some of the numbers in these studies and reviews seem high, the American Medical Informatics Association (AMIA) held a conference "Diagnostic Error in Medicine" where these issues were discussed.  Perhaps some of this speaks to need for re-engineering medical training, use of informatics on a higher level and return of the gold standard of quality assurance in medicine - the autopsy.

By Maggie Mahar and Niko Karvounis, Health Beat

This article originally appeared on Health Beat.

Despite all of the talk about medical errors and patient safety, almost no one likes to talk about diagnostic errors. Yet doctors misdiagnose patients more often than we would like to think. Sometimes they diagnose patients with illnesses they don’t have. Other times, the true condition is missed. All in all, diagnostic errors account for 17 percent of adverse events in hospitals, according to the Harvard Medical Practice Study, a landmark study that looks at medical errors.

Traditionally, these errors have not received much attention from researchers or the public. This is understandable. Thinking about missed diagnosis and wrong diagnosis makes everyone — patients as well as doctors — queasy. Especially because there is no obvious solution. But this past weekend the American Medical Informatics Association (AMIA) made a brave effort to spotlight the problem, holding its first-ever “Diagnostic Error in Medicine” conference.

Hats off to Bob Wachter, associate chairman of the Department of Medicine at the University of California, San Francisco, and the keynote speaker at the conference. Wachter shared some thoughts on diagnostic errors through his blog Wachter’s World.

Wachter begins by pointing out that a misdiagnosis lacks the concentrated shock value that is needed to grab the public imagination. Diagnostic mistakes “often have complex causal pathways, take time to play out, and may not kill for hours [i.e., if a doctor misses myocardial infarction in a patient], days (missed meningitis) or even years (missed cancers).” In short, to understand diagnostic errors, you need to pay attention for a longer period of time — not something that’s easy to do in today’s sound-bite driven culture.

Diagnostic errors just aren’t media-friendly. When someone is prescribed the wrong medication and they die, the sequence of events is usually rapid enough that the story can be told soon after the tragedy occurs. But the consequences of a mistaken diagnosis are too diffuse to make a nice, punchy story. As Wachter puts it: “They don’t pack the same visceral wallop as wrong-site surgery.”

Finally, Wachter observes, it’s hard to measure diagnostic errors. It’s easy to get an audience’s attention by telling it that “the average hospitalized patient experiences one medication error a day” or that “the average ICU patient has 1.7 errors per day in their care.”

But we don’t have equally clean numbers on missed diagnoses. As a result, he points out, “it’s difficult to convince policy makers and hospital executives, who are now obsessing about lowering the rates of hospital-acquired infections and falls” to focus on a problem that is much more difficult to tabulate.

This is a recurring problem in programs that strive to improve the quality of care: We are mesmerized by the idea of “measuring” everything. Yet, too often, what is most important cannot be easily measured. Wacther recognizes the urgency of the problem: “As quality and safety movements gallop along, the need to” address diagnostic errors” grows more pressing,” he writes. “Until we do, we will face a fundamental problem: A hospital can be seen as a high-quality organization — receiving awards for being a stellar performer and oodles of cash from P4P programs — if all of its ‘pneumonia’ patients receive the correct antibiotics, all its ‘CHF’ patients are prescribed ACE inhibitors, and all its ‘MI’ patients get aspirin and beta blockers.

“Even if every one of the diagnoses was wrong.”

Why so many errors?

Medicine is shot through with uncertainty; diseases do not always present neatly, in textbook fashion, and every human body is unique. These are just a few reasons why diagnosis is, perhaps, the most difficult part of medicine.

But misdiagnosis almost always can be traced to cognitive errors in how doctors think. When diagnosis is based on simple observation in specialties like radiology and pathology, which rely heavily on visual interpretation, error rates probably range from 2 percent to 5 percent, according to Drs. Eta S. Berner and Mark L. Graber, writing in the May issue of the American Journal of Medicine.

By contrast, in clinical specialties that rely on “data gathering and synthesis” rather than observation, error rates tend to run as high as 15 percent. After reviewing “an extensive and ever-growing literature” on misdiagnosis, Berner and Graber conclude that “diagnostic errors exist at nontrivial and sometimes alarming rates. These studies span every specialty and virtually every dimension of both inpatient and outpatient care.”

As the table below reveals, numerous studies show that the rate of misdiagnosis is “disappointingly high” both “for relatively benign conditions” and “for disorders where rapid and accurate diagnosis is essential, such as myocardial infarction, pulmonary embolism, and dissecting or ruptured aortic aneurysms.”

STUDY NAME: Shojania et al (2002)
ASSESSED CONDITION: Tuberculosis of the lungs (bacterial infection)
FINDINGS: Reviewing autopsy studies specifically focused on the diagnosis of lung TB, researchers found that 50 percent of these diagnoses were not suspected by physicians before the patient died.

STUDY: Pidenda et al (2001)
CONDITION: Pulmonary embolism ( a blood clot blocks arteries in the lungs)
FINDINGS: This study reviewed diagnosis of fatal dislodged blood clots over a five-year period at a single institution. Of 67 patients who died of pulmonary embolism, clinicians didn’t suspect the diagnosis in 37 (55 percent) of them.

STUDY: Lederle et al (1994), von Kodolitsch et al (2000)
CONDITION: Ruptured aortic aneurysm (when a weakened, bulging area in the aorta ruptures)
FINDINGS: These two studies reviewed cases at a single medical center over a seven-year period. Of 23 cases involving these aneurysms in the abdomen, diagnosis of rupture was initially missed in 14 (61 percent); in patients presenting with chest pain, doctors missed the need to dissect the bulging part of the aorta in 35 percent of cases.

STUDY: Edlow (2005)
CONDITION: Subarachnoid hemorrhage (bleeding in a particular region of the brain)
FINDINGS: This study, an updated review of published studies on this particular type of brain bleeding, shows about 30 percent are misdiagnosed on initial evaluation.

STUDY: Burton et al (1998)
CONDITION: Cancer detection
FINDINGS: Autopsy study at a single hospital: of the 250 malignant tumors found at autopsy, 111 were either misdiagnosed or undiagnosed, and in just 57 of the cases, the cause of death was judged to be related to the cancer.

STUDY: Beam et al (1996)
CONDITION: Breast cancer
FINDINGS: Looked at 50 accredited centers agreed to review mammograms of 79 women, 45 of whom had breast cancer. The centers missed cancer in 21 percent of the patients.

STUDY: McGinnis et al (2002)
CONDITION: Melanoma (skin cancer)
FINDINGS: This study, the second review of 5,136 biopsy samples found that diagnosis changed in 11 percent (1.1 percent from benign to malignant, 1.2 percent from malignant to benign, and 8 percent had a change in doctors’ ranking of how abnormal the cells were) of the samples over time, suggesting a not insignificant initial error rate.

STUDY: Perlis (2005)
CONDITION: Bipolar disorder
FINDINGS: The initial diagnosis was wrong in 69 percent of patients with bipolar disorder and delays in establishing the correct diagnosis were common.

STUDY: Graff et al (2000)
CONDITION: Appendicitis (inflamed appendix)
FINDINGS: Retrospective study at 12 hospitals of patients with abdominal pain and operations for appendicitis. Of 1,026 patients who had surgery, there was no appendicitis in 110 (10.5 percent); of 916 patients with a final diagnosis of appendicitis, the diagnosis was missed or wrong in 170 (18.6 percent).

STUDY: Raab et al (2005)
CONDITION: Cancer pathology (microscopic examination of tissues and cells to detect cancer)
FINDINGS: The frequency of errors in diagnosing cancer was measured at four hospitals over a one-year period. The error rate of pathologic diagnosis was 2 percent to 9 percent for gynecology cases and 5 percent to 12 percent for nongynecology cases; errors ran from what tissues the doctors used, to preparation problems, to misinterpretations of tissue anatomy when viewed under microscope.

STUDY: Buchweitz et al (2005)
CONDITION: Endometriosis (tissue similar to the lining of the uterus is found elsewhere in the body)
FINDINGS: Digital videotapes of the inside of patients’ bodies were shown to 108 gynecologic surgeons. Surgeons agreed only 18 percent of the time as to how many tissue areas were actually affected by this condition.

STUDY: Gorter et al (2002)
CONDITION: Psoriatic arthritis (red, scaly skin coupled with join inflammation)
FINDINGS: One of two patients with psoriatic arthritis visited 23 joint and motor specialists; the diagnosis was missed or wrong in nine visits (39 percent).

STUDY: Bogun et al (2004)
CONDITION: Atrial fibrillation (abnormal heart beat in the upper chambers of the heart)
FINDINGS: Review of doctor readings of electro-cardiograms [a graphical recording of the change in body electricity due to cardiac activity] that concluded a patient suffered from this abnormal heart beat found that: 35 percent of the patients were misdiagnosed by the machine, and the error was detected by the reviewing clinician only 76 percent of the time.

STUDY: Arnon et al (2006)
CONDITION: Infant botulism (toxic bacterial infection in newborns’ intestines)
FINDINGS: Study of 129 infants in California suspected of having botulism during a five-year period; only 50 percent of the cases were suspected at the time of admission.

STUDY: Edelman (2002)
CONDITION: Diabetes (high blood sugar due to insufficient insulin)
FINDINGS: Retrospective review of 1,426 patients with laboratory evidence of diabetes showed that there was no mention of diabetes in the medical record of 18 percent of patients.

STUDY: Russell et al (1988)
CONDITION: Chest x-rays in the emergency department
FINDINGS: One third of x-rays were incorrectly interpreted by the emergency department staff compared with the final readings by radiologists.

Overconfidence

Misdiagnosis rarely springs from a “lack of knowledge per se, such as seeing a patient with a disease that the physician has never encountered before,” Berner and Grave explain. “More commonly, cognitive errors reflect problems gathering data, such as failing to elicit complete and accurate information from the patient; failure to recognize the significance of data, such as misinterpreting test results; or most commonly, failure to synthesize or ‘put it all together.’”

The breakdown in clinical reasoning often occurs because the physician isn’t willing or able to “reflect on [his] own thinking processes and critically examine [his] assumptions, beliefs, and conclusions.” In a word, the physician is too “confident.”

Indeed, Berner and Graber find an inverse relationship between confidence and skill. In one study they reviewed, the researchers looked at diagnoses made by medical students, residents and physicians, and asked them how certain they were that they were correct. The good news is that while medical students were less accurate, they also were less confident; meanwhile the attending physicians were the most accurate and highly confident. The bad news is that the residents were more confident than the others, but significantly less accurate than the attending physicians. In another study, researchers found that residents often stayed wedded to an incorrect diagnosis even when a diagnostic decision support system suggested the correct diagnosis.

In a third study of 126 patients who died in the ICU and underwent autopsy, physicians were asked to provide the clinical diagnosis and also their level of uncertainty. Level 1 represented complete certainty, level 2 indicated minor uncertainty, and level 3 designated major uncertainty. Here the punch line is alarming: Clinicians who were “completely certain” of the diagnosis before death were wrong 40 percent of the time.

Overconfidence, or the belief that “I know all I need to know,” may help explain what the researchers describe as a “pervasive disinterest in any decision support or feedback, regardless of the specific situation.” Studies show that “physicians admit to having many questions that could be important at the point of care, but which they do not pursue. Even when information resources are automated and easily accessible at the point of care with a computer, one study found that only a tiny fraction of the resources were actually used.”

Research shows that physicians tend to ignore computerized decision-support systems, often in the form of guidelines, alerts and reminders. “For many conditions, consensus exists on the best treatments and the recommended goals,” Berner and Graber point out. Nevertheless, a comprehensive review of medical practice in the United States found that the care provided deviated from recommended best practices half of the time. In one study, the researchers suggest that the high rate of noncompliance with clinical guidelines relates to “the sociology of what it means to be a professional” in our health care system: “Being a professional connotes possessing expert knowledge in an area and functioning relatively autonomously.” Many physicians have yet to learn that 21st century medicine is too complex for anyone to know everything — even in a single specialty. Medicine has become a team sport.

But while it’s easy to blame medical “arrogance” for the high rate of errors, “there is ubstantial evidence that overconfidence — that is, miscalibration of one’s own sense of accuracy and actual accuracy — is ubiquitous and simply part of human nature,” Berner and Graber write. “A striking example derives from surveys of academic professionals, 94 percent of whom rate themselves in the top half of their profession. Similarly, only 1 percent of drivers rate their skills below that of the average driver.”

In another study published in the same issue of AMJ, Pat Croskerry and Geoff Norman note that such equanimity regarding one’s own skills can lead to what’s called “confirmation bias.” People “anchor” on findings that support their initial assumptions. Given a set of information, it’s much easier to pull out the data that proves you right and pat yourself on the back than it is to look at the contradictory evidence and rethink your assumptions. Indeed, Croskerry and Norman observe,”It takes far more mental effort to contemplate disconfirmation — by considering all the other things it might be — than confirmation.”

Making things all the more difficult is the fact that, at a certain point, the alternative to confirmation bias — what Croskerry and Norman call “consider the opposite” — becomes impractical. If a doctor embraces uncertainty, he could easily become paralyzed.

What doctors need to do is to simultaneously make a decision — and keep an open mind. Often, a doctor must embark on a course of treatment as a way of diagnosing the condition — all the time knowing that he may be wrong.

Too often, Berner and Graber observe, physicians narrow the diagnostic hypotheses too early in the process, so that the correct diagnosis is never seriously considered. Reliance on advanced diagnostic tests can encourage what they call “premature closure.” After all, high-tech diagnostic technologies offer up hard-and-fast data, fostering the illusion that the physician has vanquished medicine’s ambiguity.

But in truth, advanced diagnostic tools can miss critical information. The problem is not the technology, but how we use it. Some observers suggest that the newest and most sophisticated tools are more likely to produce false negatives because doctors accept the results so readily.

“In most cases, it wasn’t the technology that failed,” explains Dr. Atul Gawande in Complications: A Surgeon’s Notes on an Imperfect Science. “Rather, the physician did not consider the right diagnosis in the first place. The perfect test or scan may have been available, but the physician never ordered it.” Instead, he ordered another test — and believed it.

“We get this all the time,” Bill Pellan of Florida’s Penallas-Pasca County Medical Examiner’s Office told the New York Times a few years ago. “The doctor will get our report and call and say: ‘But there can’t be a lacerated aorta. We did a whole set of scans.’

“We have to remind him we held the heart in our hands.”

Autopsies

Sometimes physicians are overly confident; sometimes they narrow their hypothesis too early in the diagnostic process. Sometimes they rely too heavily on advanced diagnostic tests and accept the results too quickly. As I explained in part one of this post, these are some of the reasons why physicians misdiagnose their patients up to 15 percent of the time.

“Complacency” (i.e., the attitude that “nobody’s perfect”) also is a factor, reports Drs. Eta S. Berner and Mark L. Graber in the May issue of the American Journal of Medicine. “Complacency reflects tolerance for errors, and the belief that errors are inevitable,” they write, “combined with little understanding of how commonplace diagnostic errors are. Frequently, the complacent physician may think that the problem exists, but not in his own practice …”

It is crucial to recognize that physicians are not simply deceiving themselves: In our fragmented healthcare system, many honestly don’t know when they have misdiagnosed a patient. No one tells them — including the patient.

Sometimes a patient who isn’t getting better simply leaves the doctor and finds someone else. His original doctor may well assume that he was finally cured. Or the patient may be discharged from the hospital, relapse three months later, and go to a different ER where he discovers that his symptoms have returned because he was, in fact, misdiagnosed. The doctors who cared for him at the first hospital have no way of knowing; they think they cured him. In other cases, the patient gets better despite the wrong diagnosis. (It is surprising how often bodies heal themselves.) Meanwhile, both doctor and patient assume that the diagnosis was right and that the treatment “worked.”

In still other cases, the patient dies, and because everyone assumes that the diagnosis was correct, it is listed as the “cause of death” — when in fact, another condition killed the patient.

When giving talks to groups of physicians on diagnostic errors, Graber says that he frequently “asks whether they have made a diagnostic error in the past year. Typically, only 1 percent admit to having made such a mistake.”

Here, we reach the heart of the problem: what Berner and Graber call “the remarkable discrepancy between the known prevalence of diagnostic error and physician perception of their own error rate.” This gap “has not been formally quantified and is only indirectly discussed in the medical literature,” they note “but [it] lies at the crux of the diagnostic error puzzle and explains in part why so little attention has been devoted to this problem.”

One cannot expect doctors to learn from their mistakes unless they have feedback: At one time, autopsies provided physicians with the information they needed. And the results were regularly discussed at “mortality and morbidity” conferences, where doctors became Monday-morning quarterbacks, discussing what they could have done differently.

But today, “autopsies are done in 10 percent of all deaths; many hospitals do none,” notes Dr. Atul Gawande in Complications: A Surgeons Notes on an Imperfect Science. “This is a dramatic turnabout. Throughout much of the 20th century, doctors diligently obtained autopsies in the majority of all deaths … Autopsies have long been viewed as a tool of discovery, one that has been used to identify the cause of tuberculosis, reveal how to treat appendicitis and establish the existence of Alzheimer’s disease.

“So what accounts for the decline?” Gawande asks. “In truth, it’s not because families refuse — to judge from recent studies, they still grant their permission up to 80 percent of the time. Instead, doctors once so eager to perform autopsies that they stole bodies [from graves] have simply stopped asking.

“Some people ascribe this to shady motives,” Gawande continues. “It has been said that hospitals are trying to save money by avoiding autopsies, since insurers don’t pay for them, or that doctors avoid them in order to cover up evidence of malpractice. And yet,” he points out, “autopsies lost money and uncovered malpractice when they were popular, too.”

Gawande doesn’t believe that fear of malpractice has driven the decline in autopsies. Instead,” he writes, “I suspect, what discourages autopsies is medicine’s 21st century, tall-in-the-saddle confidence.”

This is an important point. Autopsies have fallen out of fashion in recent years: “Between 1972 and 1995, the last year for which statistics are available, the rate fell from 19.1 percent of all deaths to 9.4 percent. A major reason for the decline over this period is that “imaging technologies such as CT scanning and ultrasound have enabled doctors to ’see’ such obvious internal causes of death as tumors before the patient dies,” says Dr. Patrick Lantz, associate professor of pathology at Wake Forest University Baptist Medical Center. Nowadays an autopsy seems a waste of time and resources.

Gawande agrees: “Today we have MRI scans, ultrasound, nuclear medicine, molecular testing and much more. When somebody dies, we already know why. We don’t need an autopsy to find out … Or so I thought … ” Gawande then goes on to tell the story of a autopsy that rocked him. He had completely misdiagnosed a patient.

What autopsies show

The autopsy has been described as “the most powerful tool in the history of medicine” and the “gold standard” for detecting diagnostic errors. Indeed, Gawande points out that three studies done in 1998 and 1999 reveal that autopsies “turn up a major misdiagnosis in roughly 40 percent of all cases.”

A large review of autopsy studies concluded that, “in about a third of the misdiagnoses, the patients would have been expected to live if proper treatment had been administered,” Gawande reports. “Dr. George Lundberg, a pathologist and former editor of the Journal of the American Medical Association, has done more than anyone to call attention to these figures. He points out the most surprising fact of all: The rate at which misdiagnosis is detected in autopsy studies have not improved since at least 1938.”

When Gawande first heard these numbers he couldn’t believe them. “With all of the recent advances in imaging and diagnostics … it’s hard to accept that we have failed to improve over time.” To see if this really could be true, he and other doctors at Harvard put together a simple study. They went back into their hospital records to see how often autopsies picked up missed diagnosis in 1960 and 1970, before the advent of CT, ultrasound, nuclear scanning and other technologies, and then in 1980, after those technologies became widely used.

Gawande reports the results of the study: “The researchers found no improvement. Regardless of the decade, physicians missed a quarter of fatal infections, a third of heart attacks and almost two-thirds of pulmonary emboli in their patients who died.”

But these numbers may exaggerate the rate of error. As Berner and Graber observe, “Autopsy studies only provide the error rate in patients who die.” One can assume that the error rate is much lower in patients who survived.

“For example, whereas autopsy studies suggest that fatal pulmonary embolism is misdiagnosed approximately 55 percent of the time, the misdiagnosis rate for all cases of pulmonary embolism is only 4 percent …” a large discrepancy also exists regarding the misdiagnosis rate for myocardial infarction: although autopsy data suggest roughly 20 percent of these events are missed, data from the clinical setting (patients presenting with chest pain or other relevant symptoms) indicate that only 2 percent to 4 percent are missed.”

Still, they acknowledge that when laymen are trained to pretend to be a patient suffering from specific symptoms, studies show that “internists missed the correct diagnosis 13 percent of the time. Other studies have found that physicians can even disagree with themselves when presented again with a case they have previously diagnosed.”

On the question of whether the diagnostic error rate has changed over time, Berner and Graber quote researchers who suggest that the near-constant rate of misdiagnosis found at autopsy over the years probably reflects two factors that offset each other:

  1. diagnostic accuracy actually has improved over time (more knowledge, better tests, more skills);
  2. but as the autopsy rate declines, there is a tendency to select only the more challenging clinical cases for autopsy, which then have a higher likelihood of diagnostic error. A long-term study of autopsies in Switzerland (where the autopsy rate has remained constant at 90 percent) supports the theory that the absolute rate of diagnostic errors is, as suggested, decreasing over time.

Nevertheless, nearly everyone agrees, the rate of diagnostic errors remains too high.

We need to revive the autopsy, Gawande argues. For “autopsies not only document the presence of diagnostic errors, they also provide an opportunity to learn from one’s errors (errando discimus) if one takes advantage of the information.

“The rate of autopsy in the United States is not measured anymore,” he observes, “but is widely assumed to be significantly 10 percent. To the extent that this important feedback mechanism is no longer a realistic option, clinicians have an increasingly distorted view of their own error rates.

“Autopsy literally means “to see for oneself,” Gawande observes, and despite our knowledge and technology, when we look we are often unprepared for what we find. Sometimes it turns out that we had missed a clue along the way or made a genuine mistake. Sometimes we turn out wrong despite doing everything right.

“Whether with living patients or dead, we cannot know until we look. … But doctors are no longer asking such questions. Equally troubling, people seem happy to let us off the hook. In 1995, the United States National Center for Health Statistics stopped collecting autopsy statistics altogether. We can no longer even say how rare autopsies have become.”

If they are going to reflect on their mistakes, physicians need to “see for themselves.”

Maggie Mahar is a fellow at the Century Foundation and the author of Money-Driven Medicine: The Real Reason Health Care Costs So Much (Harper/Collins 2006).

Niko Karvounis is a program officer with the Century Foundation in New York City, where he works on issues of socioeconomic inequality and healthcare. He is a regular contributor to Health Beat, the foundation’s healthcare blog.

© 2008 Health Beat All rights reserved.

July 19, 2008

Cellumen Creates New Firm from Its Personalized Medicine Unit

Cellumen has spun off its personalized medicine unit, which will be called Cernostics Pathology. The new entity will provide tissue-based diagnostic products and services as well as digital imaging pathology.

Cernostics Pathology will build upon Cellumen’s current collaborations. The first diagnostic/theranostic test being developed is for breast cancer as part of an alliance with the Mayo Clinic and Foundation.

"Cellumen’s successful application of cellular systems biology to drug discovery, drug development, and personalized medicine over the last three years has yielded strong interest across each of these application areas,” comments D. Lansing Taylor, Ph.D., CEO of Cellumen. “Cellumen will maintain its core business by focusing on the interface between early drug discovery and early toxicity testing.”

Cernostics Pathology will also create a complete digital imaging pathology platform and build advanced informatics tools to manage, mine, and classify patient tissue samples.

July 18, 2008

New Original JibJab Cartoon

Send a JibJab Sendables® eCard Today!

Nightly Business Report on PBS story on Digital Pathology

There was a recent story on NBR on PBS about digital pathology.  Interviewed for the story were Dr. Azorides Morales from the University of Miami and Dr. Jared Schwartz, president of CAP.  Those links and link to this blog are included in the Learn More portion of the online posting.

External Links/Articles*

  • Aperio
    Aperio is a California-based firm that specializes in digital pathology systems and services.
  • College of American Pathologists (CAP)
    The College of American Pathologists is an organization of board-certified pathologists that advocates "excellence in the practice of pathology and laboratory medicine." The organization's president, Dr. Jared Schwartz, is interviewed in Jeff Yastine's report. This links to a February 2008 report in the CAP Today journal titled, "Digging Their Way In: Digital Pathology Systems."
  • Digital Pathology Blog
    The Digital Pathology Blog provides information and analysis for "the digital pathology community and laboratory professionals." The blog is sponsored by the digital pathology systems and services firm, Aperio.
  • University of Pittsburgh Medical Center (UPMC)
    As Jeff Yastine reports, the University of Pittsburgh Medical Center has teamed with GE Healthcare to form a company, Omnyx, dedicated to bringing pathology into the digital world. This links to a June 5, 2008 press release announcing the formation of the Omnyx.
  • University of Miami
    This links to the home page of the Department of Pathology in the University of Miami's Miller School of Medicine. Jeff Yastine interviews one of the university's pathology professors, Dr. Azorides Morales, in his report.

NBR on PBS Blog Not on Digital Pathology

The Big Deal about Digital Pathology

posted by Jeff Yastine, Senior Correspondent at 5:47 PM on 07/10/08

Photo of Jeff YastineWhen I first started researching tonight's story on "digital pathology" with my colleague Tess Paterekas, the first question I thought of was -- you hook up a digital camera to a pathologist's microscope, and you get "digital pathology." What’s the big deal? Of course, the big deal is that a pathologist needs to zoom in and look at very small details on a microscope slide. Have you ever tried zooming in to the tiniest elements on a digital family photograph? What happens? The resolution degrades and all the details in the picture disappear.

There are actually two major technological challenges in "digital pathology." One is getting enough detail. To examine just one microscope slide you need to render and store what amounts to 20 or 30 gigabytes of memory. The second challenge centers on the speed of the scanning process. In years past, the scan took many minutes to complete. If a hospital pathology lab is cranking out dozens and even hundreds of slides every day and each slide takes minutes and minutes to digitally scan, the idea of "digital pathology" seems highly impractical. Today, both these challenges have been mainly overcome. And, the systems that make digital pathology possible are now available at a cost more hospitals can afford.

The industry leader in digital pathology is a California-based company named Aperio. Company representatives told me that we're still in the earliest phases of a revolutionary change in pathology. What’s on the horizon? Computers and algorhythmic software that actually “read” the slides, looking for multiple "bio-markers." This advancement will automate -- and further speed up -- the diagnosis process.

How to Create Your Personal Health Record

How to Create Your Personal Health Record


from wikiHow - The How to Manual That You Can Edit

Most people do not carry medical records when they leave home. They do not realize that in case of emergency(ICE), which no one can predict, these medical records can make a big difference. In fact, they could save a life. Previous medications, history of allergy to medications, and other significant medical or surgical history can help a physician to optimize treatment.

Steps

  1. Questions to ask when creating your Personal Health Record
  2. What kind of information do you store in a Personal Health Record?
    • What information is relevant to their conditions?
    • Who can help treat an illness?
  3. Make a list of the following data:
    • DEMOGRAPHICS- Your details about name,address,sex,age,emergency contact information along with health care provider and insurance details
    • LIST OF MEDICATIONS-Current and past medications along with physician and pharmacy contact details also dosage of the Medical drugs taken.
    • ALLERGIES -To medications,environment,food or another other substance.
    • DIAGNOSIS / PROBLEM LIST-History of Diabetes,Hypertension or any other disease including duration and medications taken.
    • HISTORY OF TESTS AND PROCEDURES-Investigation reports
    • RECORD OF IMMUNIZATIONS-Childhood and also adult
    • PERTINENT FAMILY MEDICAL HISTORY-close and immediate relatives
  4. Collect the following relevant information from your health care provider
  5. * History of any medical or surgical intervention should be collected from your health care provider.

Tips

  • Make a list of all your pertinent personal health history and carry it along as paper document.
  • Store these information in USB flash drive either as word document or pdf file along with all investigation reports scanned and also images stored.
  • Insert a Medical emergency label on your personal health record file.
  • Secure the documents with password protection.

Warnings

  • The information provided on Internet should not be used to diagnose or treat any illness, disease, health problem, or metabolic disorder. Always consult your physician or health care provider before beginning any nutrition and/or exercise program and/or for medication or illness. In case of medical emergency call 911 or your local doctor

Things You'll Need

  • USB drive
  • Word Doc software
  • Scanner
  • Label

Related wikiHows


Sources and Citations

  • Markle Foundation
  • My PHR AHIMA website
  • Rahul Shetty: Portable Digital Personal Health Record : To Bridge the Digital gap in Medical Information Storage of Individuals with Personal Health Records in Flash Drives. The Internet Journal of Health. 2007. Volume 5 Number 2.
  • open medicdrive Comprehensive list of sources

Article provided by wikiHow, a collaborative writing project to build the world's largest, highest quality how-to manual. Please edit this article and find author credits at the original wikiHow article on How to Create Your Personal Health Record. All content on wikiHow can be shared under a Creative Commons license.

July 16, 2008

Nephrologist Quits Medicine to Blog Full-Time: Personal vs. Professional Use of Social Media

Featured in: hippocrates

Imagine a doctor quitting his day job to make blogging a career. Dr. Arnold Kim did just that, but he is not a typical medblogger.

This Sunday, while perusing tech industry news on Silicon Alley Insider I saw an interesting post about "The Unlikely Career Path Of MacRumors' Arnold Kim", who so happens to be a physician.

This is quite amazing, since for most blogging physicians, online publishing is mostly a hobby. Sometimes it supports professional endeavors, but rarely in a direct way. An outlet of opinions, a venue to influence healthcare dialog, even opportunity to promote themselves. But full-time?

Dr. Kim's story shows how a personal blog can turn into a career

Caveats first. Even though the blogger is a physician, his topics are not related to health or medicine. MacRumors is a site dedicated to coverage of Apple products and it took 8 years to grow to the point of taking precedence over medicine. As Arnold Kim explains in his announcement of the move:

As crazy as it seems, for these past 8 years, MacRumors has been a hobby or part-time job. I think most people would have made this move long before me, but the momentum of my “other” career made it difficult for me to break free.

I started MacRumors.com in February of 2000. I was in my 4th and last year of medical school. I had been dabbling in the web for fun and decided to focus a natural interest of mine (Apple) into a website. My work on the site has since had its ups and downs. Over the next 8 years, I completed medical school, an Internal Medicine residency, a fellowship in Nephrology and even worked two years in private practice as a physician (Nephrologist).

How successful does a blog have to be to get a physician to quit? Let's do some math. Silicon Alley Insider quotes Quantcast numbers reporting a "staggering 37 million page views a month". This makes MacRumors, #571th biggest site on the whole Internet. If we assume quite modest monetization at $1 CPM (cost per thousand pageviews), he would be making about $37K a month. If he monetizes at $10 CPM that would be $370K a month.

Suffice to say you can hardly expect a typical medical blog to get anywhere close to such numbers. Try shaving off more than a few zeros. To get the real feel for the numbers, compare to RevolutionHealth.com, which raised hundreds of millions of dollars, while only attaining #898 rank on Quantcast (detailed pageview data is not available). What could this suggest?

Health and medicine might not be as popular online topics as technology and entertainment. While highly interesting and engaging within focused communities, there might not be enough traffic to support a lot of big health properties. Which in turn makes it unlikely that we will see many physicians quitting their practices to pursue medica blogging or other Internet projects.

Final thought. Look at the numbers again and consider if the people hyping "Health 2.0" did their math and how will that party end.

July 15, 2008

Senate Passes Critical Medicare Legislation

The Senate passed critical Medicare funding legislation by a cloture vote Thursday that would prevent the 10.6 percent cut to the Medicare physician fee schedule, extend the technical component grandfather clause, and repeal the laboratory competitive bidding demonstration project.

Aided by a dramatic return to the Senate floor by Sen. Edward Kennedy (D-MA) who has been diagnosed with brain cancer, the Medicare Improvements for Patients and Providers Act of 2008, H.R. 6331, passed by a 69-30 margin.

If signed into law, the bill will repeal Medicare’s laboratory competitive bidding demonstration project, replace the scheduled 10.6 percent cut in the Medicare Physician Fee Schedule with a 1.1 percent increase, and extend the technical component “grandfather” provision for 18 months.

The Centers for Medicare & Medicaid Services distributed a memo July 7 stating that the ability of independent laboratories to bill Medicare directly for the technical component of physician pathology services furnished to beneficiaries in hospitals expired June 30—however, the legislation passed today would extend the TC “grandfather” provision retroactively from the July 1 cutoff.

The legislation now goes to the President for signature or veto—the Administration has threatened to veto the bill due to provisions cutting funding for the Medicare Advantage program.

If the President vetoes the bill—a decision on which is anticipated in the coming days—it will return to House and Senate, where a two-thirds vote would be required to override it.

The House passed their version of the 2008 Medicare funding bill on June 25 by an overwhelming vote of 355 to 59.

CAP will keep you informed on this issue and other breaking news as more information becomes available.

President Exercises Veto Power, Fails to Enact Medicare Legislation

CAP LogoAction Alert
From the CAP

Laboratorians and Pathlogists Urged to Write Congress to Override Veto

President Bush delivered on his threat to veto comprehensive Medicare legislation (H.R. 6331) which recently passed the Senate by virtue of a cloture vote 69 to 30, citing objection to provisions in the Medicare package. ASCP and CAP have been a strong proponent of the legislation as it reversed the pending 10.6 percent cut in the physician fee schedule, repealed the clinical laboratory competitive bidding demonstration project, lifted the freeze on the clinical laboratory fee schedule, and extended the technical component grandfather provisions. Despite President Bush’s veto, there is still an opportunity to enact HR 6331, the “Medicare Improvements for Patients and Providers Act of 2008;” if Congress overrides the veto. This is the process by which each chamber of Congress votes on a bill vetoed by the President. To pass a bill over the President's objections requires a two-thirds vote in each Chamber. ASCP members are urged to write their members of Congress by clicking here to Override the Veto: http://capwiz.com/ascpath/issues/alert/?alertid=11602626&type=CO

The “Medicare Improvements to Patients and Providers Act” contains numerous provisions not only of extreme importance to the laboratory community but also to Seniors and the medical community as a whole. It is vitally important that this legislation be enacted so that we can assure that Medicare beneficiaries receive quality access and care.

Many of your House and Senate Members took a bold stand initially, voting to pass this significant legislation. It is imperative that ASCP & CAP members urge all Members of Congress to vote to override. Contact your Senators and Representative and ask them to Override the Veto. The legislation remains crucial to the welfare of our patients and the laboratory.

New telemedicine service to help in the care of sick babies

5 Jul 2008

"Tiny Tom", an innovative new telemedicine service which will help with the care of sick babies in North Queensland was launched in Townsville last week on Friday, June 27.

Tiny Tom is the latest development of the tele-paediatric service, a major research project run by The University of Queensland's Centre for Online Health (COH), a research centre based in the Royal Children's Hospital in Brisbane.

COH Deputy Director, Dr Anthony Smith said the new service linked clinicians at Mackay Base Hospital, by video, with the neonatal intensive care unit (NICU) at The Townsville Hospital.

"Tiny Tom is a mobile and wireless telemedicine system that facilitates weekly virtual ward rounds between Townsville and Mackay hospitals," Dr Smith said.

"During the ward rounds at the NICU, Tiny Tom is wheeled up to an infant's beside to enable a direct video-conference consultation between the specialists in Townville and the care team in Mackay so that they can discuss the progress of the patient.

"Tiny Tom also enables parents and family members, who are unable to travel to Townsville, to see their baby and talk to NICU specialists and nursing staff," Dr Smith said.

The Executive Dean of UQ's Faculty of Health Sciences, Professor Peter Brooks, said that the Centre for Online Health was doing valuable work.

"The Centre provides paediatric consultations at a distance which has really demonstrated how these new technologies can link patients in rural and remote areas to specialists and other tertiary services that would, by their very nature, only exist in major centres.

Director of Paediatrics at Mackay Base Hospital, Dr Michael Williams praised the new service.

"This service has given us the opportunity for ongoing involvement with our babies at The Townsville Hospital thus allowing us to build up a greater awareness and understanding of the clinical issues that our babies have been experiencing and hence we have a much greater clinical understanding when they return," he said.

The research will investigate the potential economic and clinical benefits of using telemedicine in neonatal intensive care.

UQ Centre for Online Health researcher, Mr Nigel Armfield said that in addition to the potential benefits of improved continuity of care, it was hoped that Tiny Tom was a way of involving family members more fully in the ongoing care of their baby and the subsequent planning for the return home.

Tiny Tom is the fourth telemedicine system funded through the Xstrata Community Partnership Program Queensland.

Xstrata has provided $335,000 over the past three years to the UQ Centre for Online Health via the Royal Children's Hospital Foundation for the project.

This generous funding has allowed the Centre for Online Health to extend its tele-paediatric service into a number of regional areas, including Townsville and Mackay for neonatal continuity of care; Gympie and Nambour Hospital for general paediatric support; and Mount Isa and Emerald Hospitals for specialist paediatric support.

(Source: University of Queensland: July 2008)

July 14, 2008

Sunday Dilbert

Telemedicine: Opportunities for Medical and Electronic Providers

London, UK -- (SBWIRE) -- 06/11/2008 -- Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which forecasts that the global market for telemedicine will increase to over $13.9 billion by 2012, showing a compound average annual growth rate (CAGR) of 19%.

“Telemedicine: Opportunities for Medical and Electronic Providers”, which is available at http://www.reportbuyer.com/go/BCC00185 finds that telemedicine is more than a buzzword in the healthcare industry today. Healthcare players are evaluating telemedicine technology as it is expected to be part of the mainstream as telemedicine reduces costs and improves clinical outcomes.

The telemedicine market is broken down into two segments- telehospital/clinic and telehome. Of these, says the report, the telehospital segment has the largest share of the market, worth an estimated $4.4 billion in 2007. Its value is expected to reach $8.8 billion by 2012,with a CAGR of 14.7%. The telehome market, which currently accounts for 22% of the market, is expected to capture almost 37% of the
telemedicine market by 2012 and be worth $5.1 billion, up from an estimated
$1.4 billion in 2007.

In addition, authors of the report say that the telemedicine market is also divided into technology and service segments. The telemedicine technology market consisting of hardware, software, telecom and network, is expected to grow from $2.2 billion in 2007 to $5,610 million in 2012, with a CAGR of 24.8%.

Analysts say that the telemedicine service market is expected to grow from $3.6 billion in 2007 to $8.3 billion in 2012, and will be mainly driven by the telehospital service market. The telehospital market will be the largest market for both the technology and service segments. The service market will grow from $3.6 billion in 2007 to $8.3 billion in 2012 at a CAGR of 18.3%.

“Telemedicine: Opportunities for Medical and Electronic Providers” is available from Report Buyer.

For more information go to: http://www.reportbuyer.com/pharma_healthcare/ehealth/telemedicine_opportunities_medical_electronic_providers.html
About Report Buyer
Report Buyer is a UK-based independent online store supplying business information. The website now carries over 79,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

July 11, 2008

Futurescape 2008 PowerPoint and Audio Files Now Available

The PowerPoint and audio files for the 2008 Futurescape Conference have now been posted on the CAP web site.  http://www.cap.org/apps/docs/futurescape/program.html

AFIP Not To Be Dismantled Until Replacement

The Department of Defense is prohibited from expending any funds towards the disestablishment of the Armed Forces Institute of Pathology until the Joint Pathology Center has been established, with an exception for relocation of the Office of the Armed Forces Medical Examiner, according to a provision in emergency supplemental legislation signed by the President over the July 4 Congressional recess.

The provision is a victory for the College-led Coalition to Preserve the Armed Forces Institute of Pathology, compromised of approximately 35 medical specialty organizations, disease groups, and veterans’ organizations.

The Coalition initially succeeded in the addition of language to the FY 2008 National Defense Authorization Act requiring the federal government to establish the JPC, a facility similar in mission and function to AFIP.

The DoD has 180 days from passage of this legislation—a timeframe set to expire in late July—to determine if they can establish the JPC. If not, they must notify the President—who then in turn must direct establishment of the facility under another federal agency.

The Base Realignment and Closure Commission recommended the disestablishment of AFIP in July 2005. Disestablishment, without creating a new facility with a similar mission like the JPC, would threaten the education, consultation, and research services AFIP currently provides to the civilian, military, and veterans communities.

The College advocates that critical functions of AFIP must continue to operate as a whole in order to preserve it as a world-renown biomedical resource within the DoD and an irreplaceable asset for all segments of the health care community.

Sen. Ted Kennedy (D-MA) and Congressman Chris Van Hollen (D-MD) played a critical role in inserting the JPC establishment language into the authorization bill, as well as their overall leadership and provided leadership in protecting the mission and function of AFIP.

'Bill of Health" - Digital Pathology

PBS Transcript of recent story on digital pathology

Thursday, July 10, 2008

SUSIE GHARIB: In health care, digital X-rays and CT-scans have become commonplace. But the field of pathology is just beginning to enter the digital era. As Jeff Yastine reports in tonight's 'Bill of Health," it's a change that promises faster diagnoses for patients and potential cost- savings for hospitals.

JEFF YASTINE, NIGHTLY BUSINESS REPORT CORRESPONDENT: For more than a century, this is how pathologists, specialists in identifying disease through the study of human tissue, do their jobs: a high-powered microscope, and glass slides embedded with tiny slices of tissue samples. But some pathologists, like Dr. Azorides Morales, are beginning to embrace new digital pathology tools. The technology lets them rapidly scan and digitize dozens of glass slides at a time, then a pathologist can use a computer screen just like a microscope.

DR. AZORIDES MORALES, PROFESSOR OF PATHOLOGY: I will have exactly what is in this slide. And then I could focus on a specific area there and bring that up and move the slide around. So I say, OK, I want to look at this in higher magnification. And there we are.

YASTINE: Why is that a big deal? Well, until now, pathology has meant shipping lots of glass slides back and forth between pathology offices. Now these same images can be streamed over the Internet, making them instantly available to any consulting pathologist. Dr. Jared Schwartz, president of the College of American Pathologists, says digital pathology means faster diagnoses and potentially lower health care costs.

DR. JARED SCHWARTZ, PRESIDENT, COLLEGE OF AMERICAN PATHOLOGISTS: The faster you can get an accurate diagnosis and get the appropriate therapy, and the definitive therapy, you're going to lower the costs and the potential morbidity or mortality with an associated patient. I mean, if you have to have one surgical procedure, and you can get the diagnosis, that's far better than having to have two procedures.

YASTINE: Experts say the ability to electronically scan a slide is one of the keys to digital pathology. A few years ago, such scans took minutes to complete, now they take seconds. A dramatic drop in the cost of digitally storing such images is also a factor, says Gene Cartwright, CEO of Omnyx, a joint venture between GE Healthcare and the University of Pittsburgh Medical Center.

GENE CARTWRIGHT, CEO, OMNYX: The size of an image we're talking about digitizing here is about 10,000 megabytes, or 10 gigabytes for every glass slide. And so the technological challenge of scanning that image very quickly in a factory like environment, storing that image, streaming it over the Internet, and navigating around that image is a big, big challenge and one that hasn't really been possible until very recently.

YASTINE: The industry leader in sales of digital pathology gear is a California company, Aperio. But it and many others see GE's investment in Omnyx as a validation of the rapid growth expected for digital pathology. And with the average hospital pathology lab cranking out as many as 200,000 slides a year, there's a lot of room for growth in sales as hospitals begin to scan and digitize all of that medical information. Jeff Yastine, NIGHTLY BUSINESS REPORT, "Bill of Health."

The modern histopathologist: in the changing face of time

The modern histopathologist: in the changing face of time

http://www.diagnosticpathology.org/content/pdf/1746-1596-3-25.pdf

Diagnostic Pathology 2008, 3:25 doi:10.1186/1746-1596-3-25

Biman Saikia (bimansaikia@gmail.com)

Kirti Gupta (kirtigupta10@yahoo.co.in)

Uma N Saikia (umasaikia22@yahoo.co.in)

Abstract

The molecular age histopathologist of today is practicing pathology in a totally different

scenario than the preceding generations did. Histopathologists stand, as of now, on the

cross roads of a traditional ‘visible’ morphological science and an ‘invisible’ molecular

science. As molecular diagnosis finds more and more applicability in histopathological

diagnosis, it is time for the policy makers to reframe the process of accreditation and reaccreditation

of the modern histopathologist in context to the rapid changes taking place

in this science. Incorporation of such ‘molecular’ training viv-a-vis information

communication technology skills viz. telemedicine and telepathology, digital imaging

techniques and photography and a sound knowledge of the economy that the fresh entrant

would ultimately become a part of would go a long way to produce the Modern

Histopathologist. This review attempts to look at some of these aspects of this rapidly

advancing ‘art of science.’

Conclusion

So, are we looking at a histopathologist, who is not only a good traditional

morphologist, but also an IT savvy scientist, with drops of Leonardo Da Vinci and

Picasso in blood, who is ready to take technology head-on, without the inhibitions the

current generation of pathologists face and who would look at the histopathology market

with a much wider perspective of the current economy? The making of this Modern

Histopathologist would require a drastic change in the accreditation procedure and a

major initiative on the part of the policy makers and the teachers of Pathology. The

transition from a field of visual interpretations to a largely invisible molecular science

will take some time to firm foot but will eventually be there.

DVD release date of Pathology announced

Admittedly, I did not see the movie but since this is a blog about digital pathology, I think this qualifies for a short post....Also, took some liberty with the category...

MGM Home Entertainment has announced the DVD release of Pathology (review), which stars Milo Ventimiglia, Alyssa Milano, and Michael Weston. DVD Active reports that this "twisted tale of terror" will be available to own from the 23rd September, and should retail at around $27.98. The film itself will be presented in 1.85:1 anamorphic widescreen, along with an English Dolby Digital 5.1 track. Extras will include commentary by Director Marc Schoelermann and writers/producers Mark Neveldine and Brian Taylor, a Conversation with Pathologist Craig Harvey, an “Unintended Consequences” music video by Legion of Doom vs Triune, and deleted & alternate scenes.

Pathhology070808

Exclusive Corporate Sponsor

Search

  • Google

    WWW
    tissuepathology.typepad.com

Medicine 2.0

July 2008

Sun Mon Tue Wed Thu Fri Sat
   <